Lpl Financial LLC Mannkind Corp Transaction History

Lpl Financial LLC

  • $320 Billion
  • Q3 2025

A detailed history of Lpl Financial LLC transactions in Mannkind Corp stock. As of the latest transaction made, Lpl Financial LLC holds 48,911 shares of MNKD stock, worth $247,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,911
Previous 61,410 20.35%
Holding current value
$247,489
Previous $229,000 14.41%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$3.42 - $5.74 $42,746 - $71,744
-12,499 Reduced 20.35%
48,911 $262,000
Q2 2025

Aug 12, 2025
BUY
$3.71 - $5.04 $43,217 - $58,710
11,649 Added 23.41%
61,410 $229,000
Q1 2025

May 07, 2025
BUY
$4.92 - $6.6 $20,324 - $27,264
4,131 Added 9.05%
49,761 $250,000
Q4 2024

Feb 11, 2025
BUY
$5.93 - $7.44 $103,490 - $129,842
17,452 Added 61.93%
45,630 $293,000
Q3 2024

Nov 08, 2024
SELL
$5.01 - $6.7 $11,152 - $14,914
-2,226 Reduced 7.32%
28,178 $176,000
Q2 2024

Aug 07, 2024
SELL
$4.05 - $5.43 $12,028 - $16,127
-2,970 Reduced 8.9%
30,404 $158,000
Q1 2024

May 10, 2024
SELL
$3.25 - $5.27 $17,452 - $28,299
-5,370 Reduced 13.86%
33,374 $151,000
Q4 2023

Feb 14, 2024
SELL
$3.34 - $4.29 $6,813 - $8,751
-2,040 Reduced 5.0%
38,744 $141,000
Q3 2023

Nov 13, 2023
BUY
$3.91 - $5.45 $37,536 - $52,320
9,600 Added 30.79%
40,784 $168,000
Q2 2023

Jul 31, 2023
SELL
$3.72 - $4.79 $6,658 - $8,574
-1,790 Reduced 5.43%
31,184 $126,000
Q1 2023

May 10, 2023
SELL
$3.95 - $5.63 $63 - $90
-16 Reduced 0.05%
32,974 $135,000
Q4 2022

Feb 07, 2023
SELL
$3.02 - $5.37 $83,312 - $148,142
-27,587 Reduced 45.54%
32,990 $173,000
Q3 2022

Nov 14, 2022
BUY
$2.99 - $4.35 $3,940 - $5,733
1,318 Added 2.22%
60,577 $187,000
Q2 2022

Aug 12, 2022
BUY
$2.67 - $4.77 $13,216 - $23,611
4,950 Added 9.11%
59,259 $226,000
Q1 2022

May 16, 2022
SELL
$2.62 - $4.45 $1,936 - $3,288
-739 Reduced 1.34%
54,309 $200,000
Q4 2021

Feb 14, 2022
BUY
$4.05 - $5.37 $109,439 - $145,108
27,022 Added 96.42%
55,048 $241,000
Q2 2021

Aug 13, 2021
SELL
$3.61 - $5.45 $46,056 - $69,531
-12,758 Reduced 31.28%
28,026 $153,000
Q1 2021

May 14, 2021
BUY
$3.14 - $6.14 $53,763 - $105,129
17,122 Added 72.36%
40,784 $160,000
Q4 2020

Feb 12, 2021
BUY
$1.79 - $4.04 $10,149 - $22,906
5,670 Added 31.51%
23,662 $74,000
Q3 2020

Nov 09, 2020
BUY
$1.56 - $2.08 $5,460 - $7,280
3,500 Added 24.15%
17,992 $34,000
Q2 2020

Aug 13, 2020
BUY
$0.94 - $2.21 $394 - $928
420 Added 2.98%
14,492 $25,000
Q1 2020

May 14, 2020
BUY
$0.84 - $1.76 $252 - $528
300 Added 2.18%
14,072 $14,000
Q4 2019

Feb 14, 2020
SELL
$1.14 - $1.49 $20,229 - $26,440
-17,745 Reduced 56.3%
13,772 $18,000
Q3 2019

Nov 13, 2019
SELL
$1.04 - $1.44 $2,506 - $3,470
-2,410 Reduced 7.1%
31,517 $39,000
Q2 2019

Aug 09, 2019
BUY
$1.09 - $1.88 $17,183 - $29,638
15,765 Added 86.8%
33,927 $39,000
Q1 2019

May 08, 2019
SELL
$1.14 - $2.25 $205 - $405
-180 Reduced 0.98%
18,162 $36,000
Q4 2018

Feb 07, 2019
SELL
$1.02 - $2.05 $8,634 - $17,353
-8,465 Reduced 31.58%
18,342 $19,000
Q3 2018

Nov 14, 2018
BUY
$1.01 - $2.19 $3,479 - $7,544
3,445 Added 14.75%
26,807 $49,000
Q2 2018

Aug 14, 2018
SELL
$1.59 - $2.38 $95 - $142
-60 Reduced 0.26%
23,362 $44,000
Q1 2018

May 15, 2018
BUY
$2.28 - $3.8 $2,318 - $3,864
1,017 Added 4.54%
23,422 $53,000
Q4 2017

Feb 14, 2018
BUY
$2.28 - $6.71 $6,554 - $19,291
2,875 Added 14.72%
22,405 $52,000
Q3 2017

Nov 14, 2017
BUY
$1.15 - $2.29 $5,589 - $11,129
4,860 Added 33.13%
19,530 $42,000
Q2 2017

Aug 14, 2017
BUY
N/A
14,670
14,670 $21,000

Others Institutions Holding MNKD

# of Institutions
257
Shares Held
165M
Call Options Held
2.76M
Put Options Held
689K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.3B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email